Novo CEO pressed by Senate to cut costs of obesity, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the company would think about new talks with insurers concerning the record costs of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. The https://daveshotchickennutrition27161.blogdon.net/5-simple-techniques-for-healthcare-news-46821680